PharmaTher Holdings Ltd. PHRRF
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -55.75% | -16.83% | -21.49% | -28.91% | 38.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -83.94% | -48.41% | -39.02% | -0.51% | 32.20% |
| Operating Income | 83.94% | 48.41% | 39.02% | 0.51% | -32.20% |
| Income Before Tax | 119.92% | 99.34% | 33.41% | -15.35% | -9.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 119.92% | 99.34% | 33.41% | -15.35% | -9.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 119.92% | 99.34% | 33.41% | -15.35% | -9.86% |
| EBIT | 83.94% | 48.41% | 39.02% | 0.51% | -32.20% |
| EBITDA | -- | -- | -- | -- | -32.17% |
| EPS Basic | 118.18% | 100.00% | 33.33% | -12.90% | -10.00% |
| Normalized Basic EPS | 44.44% | 100.00% | 35.29% | -6.25% | -42.11% |
| EPS Diluted | 118.18% | 100.00% | 33.33% | -12.90% | -10.00% |
| Normalized Diluted EPS | 44.44% | 100.00% | 35.29% | -6.25% | -42.11% |
| Average Basic Shares Outstanding | 3.18% | 2.82% | 3.23% | 2.71% | 0.14% |
| Average Diluted Shares Outstanding | 3.18% | 2.82% | 3.23% | 2.71% | 0.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |